APC and neoplasm: Tumor cells, particularly carcinoma cells, do not express MHC class II molecules and apparently do not share phenotypic features of classical APC; thus, they do not have the possibility to stimulate Th cells and, consequently, to initiate the cascade of event leading to anti-tumor effector functions.